(17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione).
Nuovo antiandrogeno con struttura steroidea
Come funziona?
Inibisce il 5 alpha-dihydrotestosterone (5-alpha-DHT) e l’attività dei recettori del testosterone bloccando i recettori androgeni.
In this way decreasing the nuclear androgen receptors fraction. Also, series of in vivo studies demonstrated that TZP-4238 inhibited the uptake of testosterone and the decrease of DHT and testosterone.
Powerful new receptor inhibitor.
It can be used topically.
TZP-4238 hasn’t been tested on androgenetic alopecia model.
